Panchakarma Procedure (Basti Karma) And Ayurvedic Medicine (Lipistab Tablet) In The Management Of Medovaha Sroto Dushti W.S.R To Hyperlipidemia.

A Comparative Clinical Study To Evaluate The Efficacy Of Lipistab Tablet (Kalpit Yog) With Or Without Lekhniya Basti In The Management Of Medovaha Sroto Dushti W.S.R To Hyperlipidemia. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079474

Enrollment

Registered

2025-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E782- Mixed hyperlipidemia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing for study. 2. Patients between the age of 20 and 60 years. 3. If the values of Lipid Profile exceed than normal values.

Exclusion criteria

Exclusion criteria: 1.Patients not willing for study. 2.Patients having serious cardiac problems as- Myocardial Infarction, malignant hypertension, cardiac failure. 3.Patients having major illness like- IDDM and chronic uncontrolled DM II. 4.Patients having any serious renal disorder, untreated Thyroid Disorder. 5.Drug induced Hyperlipidemia e.g. -Glucocorticoid induced. 6.Pregnant and lactating females

Design outcomes

Primary

Measure	Time frame
It will lower the values of the lipid profile, including serum total cholesterol, triglycerides, low-density lipoproteins (LDL), high-density lipoproteins (HDL), very low-density lipoproteins (VLDL), and the ratio of HDL to total cholesterol.Timepoint: Assessment will be done in both the groups: 1.Day 20:At the end of the Basti. (for Group A) 2.Day 40:At the end of treatment. (For the Group B) 3.Day 60:At the time of follow up (For both the Groups A and B).	—

Measure

Time frame

It will lower the values of the lipid profile, including serum total cholesterol, triglycerides, low-density lipoproteins (LDL), high-density lipoproteins (HDL), very low-density lipoproteins (VLDL), and the ratio of HDL to total cholesterol.Timepoint: Assessment will be done in both the groups: 1.Day 20:At the end of the Basti. (for Group A) 2.Day 40:At the end of treatment. (For the Group B) 3.Day 60:At the time of follow up (For both the Groups A and B).

—

Secondary

Measure	Time frame
Measurable improvement in the following subjective sign & symptoms: 1. Weight loss 2. Chala Sphik: Flabby or unfirm buttocks 3. Chala Udara: Flabby or unfirm abdomen 4. Chala Sthana: Flabby or unfirm chest or breasts 5. Anutsaha: Lack of enthusiasm or energy 6. Krichra Vyavaaya: Difficulty in sexual activity 7. Dourbalya: Weakness or fatigue 8. Dourgandhya: Foul body odor 9. Swedhabhaada: Excessive or abnormal sweating 10. Kshudhatimatra: Excessive hunger 11. Pipasatiyoga: Excessive thirst Timepoint: Assessment will be done in both the groups: 1.Day 40:At the end of treatment(For the Group B). 2.Day 60:At the time of follow up (For both the Groups A & B).	—

Measure

Time frame

Measurable improvement in the following subjective sign & symptoms: 1. Weight loss 2. Chala Sphik: Flabby or unfirm buttocks 3. Chala Udara: Flabby or unfirm abdomen 4. Chala Sthana: Flabby or unfirm chest or breasts 5. Anutsaha: Lack of enthusiasm or energy 6. Krichra Vyavaaya: Difficulty in sexual activity 7. Dourbalya: Weakness or fatigue 8. Dourgandhya: Foul body odor 9. Swedhabhaada: Excessive or abnormal sweating 10. Kshudhatimatra: Excessive hunger 11. Pipasatiyoga: Excessive thirst Timepoint: Assessment will be done in both the groups: 1.Day 40:At the end of treatment(For the Group B). 2.Day 60:At the time of follow up (For both the Groups A & B).

—

Countries

India

Contacts

Public ContactDr Paramvir Singh

Dayanand Ayurvedic College

drparv1@gmail.com7589303536

Outcome results